Posts in category Business Standard
Utilties stocks rise (18-04-2024)
Utilties stocks were trading with gains, with the S&P BSE Utilities index increasing 56.5 points or 0.99% at 5767.83 at 09:42 IST.
Shilpa Medicare announces launch of PEMRYDI RTU (18-04-2024)
By its marketing partner Amneal Pharmaceuticals
Power Grid Corporation stock surges 5% on bagging 3 transmission projects (18-04-2024)
Further, on Wednesday, Power Grid board approved a proposal to raise up to Rs 12,000 through the issuance of bonds in one or more tranches in FY25.
Endurance approves capex of Rs 63 cr for capacity addition (18-04-2024)
Existing capacity - 584,000 casting parts per month
Existing capacity utilization - 90%
Proposed capacity addition - 8,300 casting parts per month
Investment required - Rs 63.1 crore
Capacity addition is expected to be completed in stages from October 2024 to June 2025.
Shilpa Medicare rises after marketing partner launches pemetrexed formulation in US (18-04-2024)
Shilpa Medicare advanced 1.61% to Rs 549.15 after the company informed that its marketing partner, Amneal Pharmaceuticals, has launched 'PEMRYDI RTU' (Pemetrexed injection), a ready-to-use pemetrexed formulation, in the US market.
Piramal Pharma rises after USA facility clears USFDA inspection (18-04-2024)
Piramal Pharma gained 2.09% to Rs 144.30 after the US drug regulator issued an Establishment Inspection Report (EIR) for the Riverview, USA facility stating the inspection to be closed.
Market drifts higher; breadth strong (18-04-2024)
At 09:30 IST, the barometer index, the S&P BSE Sensex, was up 333.10 points or 0.46% to 73,276.78. The Nifty 50 index advanced 98.40 points or 0.44% to 22,246.30.
Natco Pharma update on legal complaint filed in US (18-04-2024)
NATCO Pharma announced that Fresenius Kabi USA, LLC and Fresenius Kabi Deutschland GmbH (together, Fresenius) have filed a complaint against Natco Pharma USA LLC f/k/a Dash Pharmaceuticals LLC in the District Court of Delaware relating to the marketing of Dash Pharmaceuticals Diazepam Injection prefilled syringe in the United States.
Waaree Renewables Technologies Ltd Spikes 5%, S&P BSE Utilities index Rises 1.51% (18-04-2024)
Waaree Renewables Technologies Ltd has added 46.46% over last one month compared to 12.29% gain in S&P BSE Utilities index and 1.63% rise in the SENSEX
Jubilant Cadista Pharmaceuticals to close down manufacturing operations (18-04-2024)
To opt for outsourced manufacturing for US market